DE10126501A1 - Zubereitung zur Entfernung von abnormen Keratinmaterial - Google Patents
Zubereitung zur Entfernung von abnormen KeratinmaterialInfo
- Publication number
- DE10126501A1 DE10126501A1 DE10126501A DE10126501A DE10126501A1 DE 10126501 A1 DE10126501 A1 DE 10126501A1 DE 10126501 A DE10126501 A DE 10126501A DE 10126501 A DE10126501 A DE 10126501A DE 10126501 A1 DE10126501 A1 DE 10126501A1
- Authority
- DE
- Germany
- Prior art keywords
- weight
- preparation
- urea
- amount
- percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title claims abstract description 50
- 239000004202 carbamide Substances 0.000 title claims abstract description 49
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 29
- 239000000463 material Substances 0.000 title claims abstract description 26
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 102000011782 Keratins Human genes 0.000 title claims abstract description 22
- 108010076876 Keratins Proteins 0.000 title claims abstract description 22
- 230000002159 abnormal effect Effects 0.000 title claims abstract description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims description 23
- 238000002360 preparation method Methods 0.000 claims abstract description 69
- 239000000243 solution Substances 0.000 claims abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 7
- 238000004519 manufacturing process Methods 0.000 claims abstract description 6
- 239000007864 aqueous solution Substances 0.000 claims abstract description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 12
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 10
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 9
- 206010020649 Hyperkeratosis Diseases 0.000 claims description 8
- 229920001577 copolymer Polymers 0.000 claims description 8
- 210000004905 finger nail Anatomy 0.000 claims description 8
- 210000004906 toe nail Anatomy 0.000 claims description 8
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 239000004310 lactic acid Substances 0.000 claims description 6
- 235000014655 lactic acid Nutrition 0.000 claims description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 6
- 239000000470 constituent Substances 0.000 claims description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims description 4
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 4
- 208000000260 Warts Diseases 0.000 claims description 4
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 4
- 201000010153 skin papilloma Diseases 0.000 claims description 4
- 201000004681 Psoriasis Diseases 0.000 claims description 3
- 230000002538 fungal effect Effects 0.000 claims description 3
- 230000036571 hydration Effects 0.000 claims description 3
- 238000006703 hydration reaction Methods 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 2
- 239000011976 maleic acid Substances 0.000 claims description 2
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 229920006149 polyester-amide block copolymer Polymers 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 2
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 claims description 2
- 206010017533 Fungal infection Diseases 0.000 claims 1
- 208000031888 Mycoses Diseases 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000003039 volatile agent Substances 0.000 abstract 1
- 210000000282 nail Anatomy 0.000 description 15
- 210000003491 skin Anatomy 0.000 description 6
- 208000010195 Onychomycosis Diseases 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 201000005882 tinea unguium Diseases 0.000 description 4
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 4
- 229940121375 antifungal agent Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- OCAPBUJLXMYKEJ-UHFFFAOYSA-N 1-[biphenyl-4-yl(phenyl)methyl]imidazole Chemical compound C1=NC=CN1C(C=1C=CC(=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 OCAPBUJLXMYKEJ-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000013773 glyceryl triacetate Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229960002622 triacetin Drugs 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028703 Nail psoriasis Diseases 0.000 description 1
- 206010048886 Onychoclasis Diseases 0.000 description 1
- 229920002685 Polyoxyl 35CastorOil Polymers 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- GEHJBWKLJVFKPS-UHFFFAOYSA-N bromochloroacetic acid Chemical compound OC(=O)C(Cl)Br GEHJBWKLJVFKPS-UHFFFAOYSA-N 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000012943 effectiveness check Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- SYJRVVFAAIUVDH-UHFFFAOYSA-N ipa isopropanol Chemical compound CC(C)O.CC(C)O SYJRVVFAAIUVDH-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000004611 light stabiliser Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 125000005397 methacrylic acid ester group Chemical group 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000026721 nail disease Diseases 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- QUANRIQJNFHVEU-UHFFFAOYSA-N oxirane;propane-1,2,3-triol Chemical compound C1CO1.OCC(O)CO QUANRIQJNFHVEU-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000008389 polyethoxylated castor oil Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229940024473 salicylic acid emollient and protective preparations Drugs 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- RNWHGQJWIACOKP-UHFFFAOYSA-N zinc;oxygen(2-) Chemical compound [O-2].[Zn+2] RNWHGQJWIACOKP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10126501A DE10126501A1 (de) | 2001-05-30 | 2001-05-30 | Zubereitung zur Entfernung von abnormen Keratinmaterial |
| AT02732724T ATE296607T1 (de) | 2001-05-30 | 2002-05-17 | Zubereitung zur entfernung von abnormen keratinmaterial |
| MXPA03009984A MXPA03009984A (es) | 2001-05-30 | 2002-05-17 | PREPARACION PARA LA REMOCIoN DE MATERIAL QUERATINOSO ANORMAL. |
| DE50203283T DE50203283D1 (de) | 2001-05-30 | 2002-05-17 | Zubereitung zur entfernung von abnormen keratinmaterial |
| PT02732724T PT1395231E (pt) | 2001-05-30 | 2002-05-17 | Preparacao para a remocao de material queratinoso anormal |
| ES02732724T ES2242027T3 (es) | 2001-05-30 | 2002-05-17 | Preparacion para eleminar material queratinoso anormal. |
| CA2448829A CA2448829C (en) | 2001-05-30 | 2002-05-17 | Preparation for the removal of abnormal keratinous material |
| EP02732724A EP1395231B1 (de) | 2001-05-30 | 2002-05-17 | Zubereitung zur entfernung von abnormen keratinmaterial |
| DK02732724T DK1395231T3 (da) | 2001-05-30 | 2002-05-17 | Præparat til fjernelse af abnormt keratinmateriale |
| JP2003501422A JP4359140B2 (ja) | 2001-05-30 | 2002-05-17 | 異常な角質性物質を除去するための製剤 |
| PCT/EP2002/005469 WO2002098380A1 (de) | 2001-05-30 | 2002-05-17 | Zubereitung zur entfernung von abnormen keratinmaterial |
| US10/156,070 US20020197291A1 (en) | 2001-05-30 | 2002-05-29 | Composition for removing abnormal keratinous material |
| US10/757,433 US7476396B2 (en) | 2001-05-30 | 2004-01-15 | Composition for removing abnormal keratinous material |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10126501A DE10126501A1 (de) | 2001-05-30 | 2001-05-30 | Zubereitung zur Entfernung von abnormen Keratinmaterial |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE10126501A1 true DE10126501A1 (de) | 2002-12-12 |
Family
ID=7686754
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE10126501A Withdrawn DE10126501A1 (de) | 2001-05-30 | 2001-05-30 | Zubereitung zur Entfernung von abnormen Keratinmaterial |
| DE50203283T Expired - Lifetime DE50203283D1 (de) | 2001-05-30 | 2002-05-17 | Zubereitung zur entfernung von abnormen keratinmaterial |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE50203283T Expired - Lifetime DE50203283D1 (de) | 2001-05-30 | 2002-05-17 | Zubereitung zur entfernung von abnormen keratinmaterial |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20020197291A1 (enExample) |
| EP (1) | EP1395231B1 (enExample) |
| JP (1) | JP4359140B2 (enExample) |
| AT (1) | ATE296607T1 (enExample) |
| CA (1) | CA2448829C (enExample) |
| DE (2) | DE10126501A1 (enExample) |
| DK (1) | DK1395231T3 (enExample) |
| ES (1) | ES2242027T3 (enExample) |
| MX (1) | MXPA03009984A (enExample) |
| PT (1) | PT1395231E (enExample) |
| WO (1) | WO2002098380A1 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005018585A1 (de) * | 2003-08-25 | 2005-03-03 | Bioequal Ag | Pharmazeutische und kosmetische formulierungen zur behandlung der nägel |
| EP2750669A4 (en) * | 2011-08-31 | 2014-11-12 | Avon Prod Inc | COSMETIC LIQUID EXTRACTOR COMPRISING NON-IONIC POLYMERS |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE50012415D1 (de) * | 2000-01-03 | 2006-05-11 | Karl Kraemer | Zubereitungen zur atraumatischen nagelentfernung |
| DE10126501A1 (de) * | 2001-05-30 | 2002-12-12 | Aventis Pharma Gmbh | Zubereitung zur Entfernung von abnormen Keratinmaterial |
| ES2337359T3 (es) * | 2003-04-24 | 2010-04-23 | L'oreal | Procedimiento de exfoliacion que utiliza urea. |
| DE102006049586A1 (de) * | 2006-10-22 | 2008-04-24 | Rudy Susilo | Nagellackenferner für kosmetische und medizinische Anwendungen |
| US8293174B2 (en) * | 2007-10-17 | 2012-10-23 | American Sterilizer Company | Prion deactivating composition and methods of using same |
| US20090191138A1 (en) * | 2008-01-30 | 2009-07-30 | Mediquest Therapeutics, Inc. | Novel topical formulations for improving the appearance of nails |
| NL1035426C2 (nl) * | 2008-05-15 | 2009-11-17 | Atp Marketing & Promotion Ag | Farmaceutische samenstellingen voor de behandeling van wratten. |
| FR2937250B1 (fr) * | 2008-10-21 | 2013-05-10 | Fabre Pierre Dermo Cosmetique | Solution filmogene a base d'uree pour le traitement du psorasis de l'ongle |
| KR101055963B1 (ko) * | 2008-12-01 | 2011-08-11 | (주)더페이스샵 | 각질 박리 촉진용 화장료 조성물 |
| WO2012110430A1 (en) * | 2011-02-10 | 2012-08-23 | Moberg Derma Ab | Novel composition for topical use on a nail |
| US9770609B2 (en) | 2015-04-01 | 2017-09-26 | Neat Feat Products Limited | Urea based skin treatment |
| CN116211725A (zh) * | 2022-12-13 | 2023-06-06 | 无锡知妍生物科技有限公司 | 一种洗去类高浓度尿素去角质凝胶及其制备方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4402935A (en) * | 1981-04-16 | 1983-09-06 | Del Laboratories, Inc. | Moisturizing nail polish composition |
| DE3520098A1 (de) * | 1985-06-05 | 1986-12-11 | Bayer Ag, 5090 Leverkusen | Azolderivate enthaltende formulierungen sowie ihre verwendung zur atraumatischen nagelentfernung |
| DE3687458T2 (de) | 1985-11-04 | 1993-07-29 | Owen Galderma Lab Inc | Filmbildende arzneimitteltraeger zur verabreichung von arzneimitteln an naegeln |
| DE3544983A1 (de) * | 1985-12-19 | 1987-06-25 | Hoechst Ag | Antimykotisch wirksamer nagellack |
| FR2613227B1 (fr) * | 1987-04-01 | 1990-12-28 | Oreal | Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles |
| DE3720147A1 (de) | 1987-06-16 | 1988-12-29 | Hoechst Ag | Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung |
| US5098421A (en) * | 1989-10-16 | 1992-03-24 | Zook Gerald P | Viscoelastic gel foot padding and medicating device |
| DE4212105A1 (de) | 1992-04-10 | 1993-10-14 | Roehm Pharma Gmbh | Nagellack zur Behandlung von Onychomykosen |
| US5460620A (en) * | 1992-07-31 | 1995-10-24 | Creative Products Resource, Inc. | Method of applying in-tandem applicator pads for transdermal delivery of a therapeutic agent |
| WO1994013257A1 (en) * | 1992-12-16 | 1994-06-23 | Creative Products Resource Associates, Ltd. | Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder |
| DE4337945A1 (de) | 1993-11-06 | 1995-05-11 | Labtec Gmbh | Pflaster zur Behandlung von Nagelmykosen |
| US5639740A (en) * | 1995-03-10 | 1997-06-17 | Crandall; Wilson Trafton | Topical moisturizing composition and method |
| US5834513A (en) * | 1996-04-25 | 1998-11-10 | Avon Products, Inc. | Oxa diacids and related compounds for treating skin conditions |
| US5993790A (en) * | 1997-08-04 | 1999-11-30 | Pedinol Pharmacal Inc. | Nail evulsion compositions and method for evulsing nails and treating nail and nail bed infections |
| US5919470A (en) * | 1998-04-02 | 1999-07-06 | Bradley Pharmaceuticals, Inc. | Dermatological composition |
| DE50012415D1 (de) * | 2000-01-03 | 2006-05-11 | Karl Kraemer | Zubereitungen zur atraumatischen nagelentfernung |
| US6281239B1 (en) * | 2000-04-12 | 2001-08-28 | Bradley Pharmeaceuticals, Inc. | Method of treating onychomycosis |
| DE10126501A1 (de) * | 2001-05-30 | 2002-12-12 | Aventis Pharma Gmbh | Zubereitung zur Entfernung von abnormen Keratinmaterial |
| US6429231B1 (en) * | 2001-09-24 | 2002-08-06 | Bradley Pharmaceuticals, Inc. | Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use |
| US6753071B1 (en) * | 2001-09-27 | 2004-06-22 | Advanced Cardiovascular Systems, Inc. | Rate-reducing membrane for release of an agent |
| US6495602B1 (en) * | 2001-12-13 | 2002-12-17 | Bradley Pharmaceuticals, Inc. | Topical pharmaceutical base with anti-pruritic and/or anti-inflammatory drugs |
| US6673842B2 (en) * | 2002-03-20 | 2004-01-06 | Bradley Pharmaceuticals, Inc. | Method of treating onychomycosis |
| US6743417B2 (en) * | 2002-04-22 | 2004-06-01 | Bradley Pharmaceuticals, Inc. | Method of treating onychomycosis with urea and an antioxidant |
| US6573301B1 (en) * | 2002-04-23 | 2003-06-03 | Bradley Pharmaceuticals, Inc. | Carbamide peroxide compositions for the treatment of dermatological disorders and methods for their use |
-
2001
- 2001-05-30 DE DE10126501A patent/DE10126501A1/de not_active Withdrawn
-
2002
- 2002-05-17 PT PT02732724T patent/PT1395231E/pt unknown
- 2002-05-17 AT AT02732724T patent/ATE296607T1/de active
- 2002-05-17 DK DK02732724T patent/DK1395231T3/da active
- 2002-05-17 CA CA2448829A patent/CA2448829C/en not_active Expired - Fee Related
- 2002-05-17 ES ES02732724T patent/ES2242027T3/es not_active Expired - Lifetime
- 2002-05-17 EP EP02732724A patent/EP1395231B1/de not_active Expired - Lifetime
- 2002-05-17 MX MXPA03009984A patent/MXPA03009984A/es active IP Right Grant
- 2002-05-17 WO PCT/EP2002/005469 patent/WO2002098380A1/de not_active Ceased
- 2002-05-17 JP JP2003501422A patent/JP4359140B2/ja not_active Expired - Fee Related
- 2002-05-17 DE DE50203283T patent/DE50203283D1/de not_active Expired - Lifetime
- 2002-05-29 US US10/156,070 patent/US20020197291A1/en not_active Abandoned
-
2004
- 2004-01-15 US US10/757,433 patent/US7476396B2/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005018585A1 (de) * | 2003-08-25 | 2005-03-03 | Bioequal Ag | Pharmazeutische und kosmetische formulierungen zur behandlung der nägel |
| EP2750669A4 (en) * | 2011-08-31 | 2014-11-12 | Avon Prod Inc | COSMETIC LIQUID EXTRACTOR COMPRISING NON-IONIC POLYMERS |
Also Published As
| Publication number | Publication date |
|---|---|
| DK1395231T3 (da) | 2005-09-12 |
| PT1395231E (pt) | 2005-08-31 |
| JP2004532268A (ja) | 2004-10-21 |
| EP1395231B1 (de) | 2005-06-01 |
| US20040146555A1 (en) | 2004-07-29 |
| WO2002098380A1 (de) | 2002-12-12 |
| CA2448829A1 (en) | 2002-12-12 |
| EP1395231A1 (de) | 2004-03-10 |
| US20020197291A1 (en) | 2002-12-26 |
| ATE296607T1 (de) | 2005-06-15 |
| CA2448829C (en) | 2010-04-20 |
| US7476396B2 (en) | 2009-01-13 |
| MXPA03009984A (es) | 2004-02-12 |
| JP4359140B2 (ja) | 2009-11-04 |
| DE50203283D1 (de) | 2005-07-07 |
| ES2242027T3 (es) | 2005-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0298271B1 (de) | Antimykotisch wirksamer Nagellack sowie Verfahren zu dessen Herstellung | |
| DE3687458T2 (de) | Filmbildende arzneimitteltraeger zur verabreichung von arzneimitteln an naegeln | |
| EP0226984B1 (de) | Antimykotisch wirksamer Nagellack | |
| EP1395231B1 (de) | Zubereitung zur entfernung von abnormen keratinmaterial | |
| DE10228837B4 (de) | Hautkosmetische Zusammensetzung und Verwendung der Zusammensetzung als Hautbräunungsmittel | |
| EP0879052B1 (de) | Nagelwachstumsfördernde zubereitungen | |
| EP0913154B1 (de) | Antipsoriatisch wirksamer Nagellack | |
| WO2000015202A2 (de) | Topisch anwendbare mittel | |
| WO1992012699A1 (de) | Kosmetische oder pharmazeutische zubereitungen zur verbesserung der haarqualität und förderung des haarwachstums | |
| EP1263426B1 (de) | Zubereitungen zur atraumatischen nagelentfernung | |
| DE1804801C3 (de) | Mittel zur Aknebehandlung | |
| EP3820436B1 (de) | Selbstklebende flächige produkte enthaltend ein oder mehrere alkylamidothiazole | |
| DE69803119T2 (de) | Verwendung von Sulfiten und Metabisulfiten zur Herstellung von kosmetischen oder pharmazeutischen, insbesondere dermatologischen Zusammensetzungen, welche einen inhibitorischen Effekt auf die Melanogenese oder eine hautdepigmentierende Wirkung besitzen | |
| WO2005018585A1 (de) | Pharmazeutische und kosmetische formulierungen zur behandlung der nägel | |
| EP0645135A1 (de) | Hämodialysat enthaltendes Sonnenschutzmittel | |
| DE69903166T2 (de) | Verfahren zur gewinnung von fibrillin aus cnidaria und entsprechende kosmetische zusammensetzungen | |
| WO2013135854A1 (de) | Kosmetikprodukte für die altershaut | |
| DE3147727C2 (de) | Wundheilmittel enthaltend Kollagen aus Basalmembranen | |
| JP3219401B1 (ja) | 殺菌作用を有する組成物、該組成物からなる化粧料及び紫外線遮断材 | |
| DE3046133C1 (de) | Kosmetische Praeparate enthaltend Kollagen aus Basalmembranen | |
| EP1517691A1 (de) | Verwendung von dopamin-rezeptor-agonisten zur behandlung von hautgeschw lsten, warzen und narben | |
| DE20221245U1 (de) | Selbstklebende Polymermatrix mit einem Gehalt an Meeresalgenextrakt und Glycerin | |
| DE20221246U1 (de) | Selbstklebende Polymermatrix mit einem Gehalt an Meeresalgenextrakt und Glycerin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OP8 | Request for examination as to paragraph 44 patent law | ||
| 8130 | Withdrawal |